Use of interferon to treat hepatitis C in patients with liver and kidney transplantation: a case report

Authors

  • Paulo Roberto Ramos Alves Acadêmico de Medicina da Universidade do Planalto Catarinense - Lages/SC – Brasil.
  • Thaise Brighente Volpato Acadêmico de Medicina da Universidade do Planalto Catarinense - Lages/SC – Brasil.
  • Maíra Silva de Godoy Equipe de Transplante Hepático do Hospital Santa Isabel- Blumenau/SC – Brasil.
  • Camila Pilati Drago Equipe de Transplante Hepático do Hospital Santa Isabel- Blumenau/SC – Brasil.
  • Marcelo Augusto Scheidemantel Nogara Equipe de Transplante Hepático do Hospital Santa Isabel- Blumenau/SC – Brasil.

DOI:

https://doi.org/10.53855/bjt.v15i1.175

Keywords:

Liver Transplantation, Renal Transplantation, Hepatitis C, Interferon, Graft Rejection

Abstract

The treatment for hepatitis C using pegylated interferon and ribavirin in renal transplanted patients has been much discussed due to the possibility of graft rejection. This paper aims to report the case of a transplanted kidney and liver under treatment for hepatitis C using pe- gylated interferon and Ribavirin with scheduled duration of 48 weeks. The patient is in the 31th week of treatment, and he showed reduced viral load and preservation of the liver and kidney functions. During the review of the subject it was noted that this is still controversial; however, recent studies has shown the effectiveness of treatment restraining the virus and preserving the renal graft.

Downloads

Download data is not yet available.

Downloads

Published

2012-01-01

How to Cite

Alves, P. R. R., Volpato, T. B., Godoy, M. S. de ., Drago, C. P., & Nogara, M. A. S. (2012). Use of interferon to treat hepatitis C in patients with liver and kidney transplantation: a case report. Brazilian Journal of Transplantation, 15(1), 1642–1645. https://doi.org/10.53855/bjt.v15i1.175

Issue

Vol. 15 No. 1 (2012)

Section

Case Report